Since the complete sequencing of a human major histocompatibility complex (MHC) haplotype, interest in non-human leucocyte antigen (HLA) genes encoded in the MHC has been growing. Non-HLA genes, which outnumber the HLA genes, may contribute to or account for HLA and disease associations. Most information on non-HLA genes has been obtained in separate studies of individual loci. To comprehensively address polymorphisms of relevant non-HLA genes in 'conserved extended haplotypes' (CEH), we investigated 101 International Histocompatibility Workshop reference cell lines and nine additional anonymous samples representing all 37 unambiguously characterized CEHs at MICA, NFKBIL1, LTA, NCR3, AIF1, HSPA1A, HSPA1B, BF, NOTCH4 and a single nucleotide polymorphism (SNP) at HLA-DQA1 as well as MICA, NOTCH4, HSPA1B and all five tumour necrosis factor short tandem repeat (STR) polymorphisms. This work (1) provides an extensive catalogue of MHC polymorphisms in all CEHs, (2) unravels interrelationships between HLA and non-HLA haplotypical lineages, (3) resolves reported typing ambiguities and (4) describes haplospecific markers for a number of CEHs. Analysis also identified a DQA1 SNP and segments containing MHC class III polymorphisms that corresponded with class II (DRB3 and DRB4) lineages. These results portray the MHC where lineages containing non-HLA and HLA variants in linkage disequilibrium may operate in concert and can guide more thorough design and interpretation of HLA-disease relationships.
Introduction
The human major histocompatibility complex (MHC) contains more than 200 expressed genes, 1 but most studies still concentrate disproportionally on classical human leucocyte antigen (HLA) genes. Most associations with HLA alleles have been treated as primary associations even in the absence of a documented functional role for the allele, and without excluding the involvement of other closely linked genes, whose variants are obviously in linkage disequilibrium (LD) with the disease-associated HLA allele. Associations detected with candidate markers elsewhere in the genome would routinely be accompanied by analysis of LD with adjacent genes, but HLA associations are all too readily interpreted as evidence for an infectious etiology or an immunopathogenetic component without any such an attempt. Although such an interpretation may be the correct one at times, many other MHC genes deserve attention as alternative explanations for HLA associations. Some investigators have considered these non-HLA genes [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and these efforts would be facilitated by better characterization of the relationships among these MHC genes.
Some well-known non-HLA genes of the MHC are those encoding steroid 21-hydroxylase (CYP21A2), an enzyme involved in adrenal steroid biosynthesis; factor B (BF), a complement component; three 70 kDa heat-shock proteins (HSPA1A, HSPA1B, HSPA1L); natural cytotoxicity triggering receptor 3 (NCR3, also known as 1C7); nuclear factor kappa light chain gene enhancer in B cells inhibitor-like 1 (NFKBIL1), an NF-kappa-B regulator; proto-oncogene NOTCH4 (Notch homologue 4); and allograft inflammatory factor 1 (AIF1). NOTCH4 and AIF1 gene products are also relevant in angiogenesis. 19, 20 Besides these, genes for tumour necrosis factor (TNF) and lymphotoxin alpha (LTA) are located in the class III region of the human MHC. Some of these genes have been examined for their relationships to the HLA haplotypes 2, 3, [21] [22] [23] [24] [25] [26] [27] [28] [29] or in single populations [30] [31] [32] [33] [34] but not in relation to each other nor collectively in a single study. Recent comprehensive population studies are restricted to European/North American samples. [30] [31] [32] [33] 35 Latest definitions of 'conserved extended haplotypes' (CEH), whole MHC haplotypes with fixed constellations of alleles, still lack information on most of the non-HLA genes [36] [37] [38] (these unique haplotypes are also called ancestral haplotypes (AH) 39 ). Although our aim was to better characterize all 37 CEHs and resolve discrepant published results, a secondary aim was to identify markers of ancestral haplotypic lineages (mainly the DRB3 and DRB4/5 lineages) to be used in detailed studies of associations.
We have been involved in studies on HLA associations with prenatal selection, longevity, [40] [41] [42] leukaemias and HIV-related Kaposi's sarcoma. 43 These studies revealed associations with HLA class II haplotypic groups represented by HLA-DRB3 and DRB4 encoding DR52 and DR53 serological specificities (the original HLA class II supertypes), respectively. Being divergent evolutionary lineages, these groups have distinct immunological features that may account for their opposite effects in susceptibility. 44 We tried to describe the non-HLA sections of these haplotypic groups to delineate their possible role as markers of disease susceptibility. As an extension of our previous findings with a single polymorphism in the HSPA1B (HSP70-2) gene, 45 we examined two of the HSP genes more comprehensively. We chose to address these questions primarily on the International Histocompatibility Workshop (IHW) reference cell lines representing all 37 CEHs mainly in homozygous form. This panel was supplemented by additional samples from anonymous subjects.
Results
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We also considered the two HLA class II region polymorphisms causing amino-acid (aa) substitutions in DRB1 (position 86) and DQB1 (position 57) that are relevant in disease associations. These two aa variants and the DQA1 3 0 UTR SNP yielded nine haplotypes. Out of these, DRB1-86glycine-DQB1-57alanine-DQA1*499C (haplotype GAC) occurred on eight of the DRB4 haplotypes but the reciprocal haplotype (VDA) only occurred on three rare DRB3 haplotypes. The main reason for this was the presence of alanine (A) at position 57 of the DQB1 chain in the common DRB3 and DRB4 haplotypes. Thus, the DRB1 and DQB1 variants at the specific aa positions did not improve the correlation of DQA1 3 0 UTR SNP alleles with ancestral lineages. These HLA class II haplotypes of each CEH are shown in Table 2 .
HSPA1A and HSPA1B
The cell lines previously typed by Southern blotting by us 45, 47, 48 and others 22 gave the expected results by the PCR-RFLP analysis of SNP þ 1267A4G. We increased the number of cell lines analysed and also examined the HSPA1B short tandem repeat (STR) and HSPA1A promoter sequence. HSPA1A promoter polymorphisms strongly correlated with HSPA1B SNP 1267A4G (see below), but there was a degree of disagreement between the HSPA1B SNP and STR alleles A1 (183 bp) and A2 (188 bp). Although all cell lines homozygous for PstI RFLP allele 1267A were also homozygous for the STR allele A1, few samples homozygous for allele 1267G also carried the STR allele A1. These were the representatives of CEH 37.1, 42.1, 47.1 and 60.3. JHAF (B*5101, DRB1*0407) was another cell line that showed this disagreement. Because of the strong relationship between HSPA1B SNP and HLA-DRB3/4/5 lineages or HLA-DQA1 3 0 UTR SNP, the use of the SNP should be preferable to the STR in the analysis of HSPA1B in ancestral lineage studies.
We investigated the correlation between the HSPA1B polymorphisms and HSPA1A promoter polymorphisms. All CEHs with þ 1267A had À325T and À26C (T-C-A haplotype) and all but two CEHs with þ 1267G had À325G and À26G (G-G-G haplotype). The two exceptions were the cell lines PLH (CEH 47.1) and CBB6 (CEH 62.3). These rare haplotypes had the combination of HSPA1A À315T, À26C and HSPA1B þ 1267G (T-C-G haplotype). Thus, the HSPA1B SNP þ 1267A4G was in general able to predict the HSPA1A promoter haplotypes. The HSPA1A promoter sequencing revealed a novel SNP (À130G4C) that was observed in only two chromosomes from one cell line (PLH; CEH 47.1). An AluI PCR-RFLP also identified this SNP. This change was not owing to a sequencing artefact as confirmed by PCR-RFLP analysis on CEH 47.1, but was not found on additional samples analysed by PCR-RFLP. No other example of the HLA-B*4701, DRB1*0701 haplotype was available, and the haplospecific SNP in the promoter region of HSPA1A (À130G4C) remains subject to replication in further examples of CEH 47.1. This SNP may be a marker in LD with CYP21A2 deletion characteristic of CEH 47.1. 49 When correlations between the two HSP haplotypes HSPA1A À325T, À26C, HSPA1B þ 1267A (TCA)/ HSPA1A À325G, À26G, HSPA1B þ 1267G (GGG) and 499A4C ) and another at HSPA1B (1267A4G), we were able to divide all major MHC class II haplotypes into broad groups that correlate with their evolutionary histories (see Discussion). The correlation was not absolute and there were few exceptions that included relatively rare haplotypes, most notably the HLA-B*1302, DRB1*0701 haplotype (CEH 13.1) did not fall into the same group as other DRB4 haplotypes.
NOTCH4
In this first comprehensive analysis of the two NOTCH4 polymorphisms in CEHs ( [36] [37] [38] 53 report the complotype of CEH 18.2 as CF1,3Q0 (corresponding to BF*F), whereas our molecular typing showed BF*S. These examples indicate the need for accurate characterization of complotypes in CEHs at the DNA level.
AIF1-NCR3-TNF/LTA-NFKBIL1
The remaining class III loci typed in this study are all at the telomeric end of this region. The gene order of the analysed loci is AIF1-NCR3-TNF STRs-LTA-NFKBIL1, from centromere to telomere (Figure 1 ). The genes in this block are close to each other and because three of them, AIF1, LTA and NFKBIL1, showed strong correlation, they were analysed as a haplotypic unit (ALN haplotype). Most common haplotypes were associated with LTA þ 252G (TNFB*1)-NFKBIL1 À62T (GT haplotype) or LTA þ 252A (TNFB*2)-NFKBIL1 À62A (AA haplotype), whereas haplotype AT did not exist and GA was present only on CEH 60.3. Inclusion of AIF1 typing increased the number of lineages to five with a total absence of the A-T-G haplotype (Table 4) .
Although limited, the polymorphisms of NCR3 showed correlations with haplotype groups. NCR3 À451 variant allele A was observed on CEHs 51.1; 54.1; 55.1, which also shared the ALN haplotype TAA and MICA STR allele A4. To examine the possibility that it may be common to HLA-B22 serogroup consisting of B*54, B*55 and B*56, we typed 18 additional samples from a recent study on the effect of HLA-B22 serogroup on HIV progression. 55 We found this allele on 14 HLA-B*55-positive samples but not on any of four samples positive for B*56. Therefore, the NCR3 promoter allele À451A was a common marker for B*54 and B*55, two of the three alleles making up the HLA-B22 serogroup. It was, however, also present on CEH 51.1. This allele was detected on another cell line (KOSE; HLA-B*3503, DRB1*1302/1401), which is heterozygous at HLA-DRB1 and does not represent any CEH. All haplotypes with NCR3 variant À451A shared TNFc1, LTA þ 252G, NFKBIL1 À62T. The other promoter variant À412C was consistently present on more than one sample with CEH 42.1, 46.1 and 46.2. CEH 62.3 and two heterozygous cell lines KT14 and KT17 that do not represent any CEH were also positive for this NCR3 variant. All of the À412C-positive haplotypes were also positive for TNFc1, LTA 252G and NFKBIL1 À62T. Thus, both NCR3 promoter variants were on TNFc1 haplotypes and may contribute to TNFc1 disease associations.
TNF STR
Although reports on TNF STR data for CEH are numerous, 38, 53, 54, [56] [57] [58] they are by no means complete. We have retyped all representatives of CEHs at five STRs using the original method 53 but with non-radioactive labelling of primers. We noted a few discrepancies between our results and previous ones. The cell lines SLE005 and EMJ have identical HLA-B, C, DR and DQ types, 59 but the most comprehensive study of TNF STR loci to date has found that SLE005 is homozygous at all TNF loci but EMJ is not. 53 Our typings confirm that both cell lines are, as expected, homozygous at the TNF STR loci for the same alleles. Likewise, MT14B is also homozygous at TNFa and TNFb but not heterozygous as reported in the same study. 53 In agreement with the previous report, we confirmed isolated heterozygosity at TNFd in otherwise homozygous cell line L0081785 (CEH 18.2). TISI, representing CEH 35.4, was found homozygous at all loci analysed except TNFd. Although this cell line was originally reported as homozygous, we repeatedly found it heterozygous at TNFd while still homozygous at other STR loci. This may be another example of instability at STR loci. 31, 54 The cell line COX is homozygous for the HLA-A*01-B*08, DRB1*03 haplotype. The origin of this cell line is a parent-child mating and the two chromosomes are identical by descent, that is, homozygosity is due to autozygosity. Other examples of this haplotype carry TNFa2 but COX has the very rare allele a3. This is perhaps an isolated case of mutation in that family, which is common in STR loci. The only other example of 
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TNFa3 was on the cell line BOB (HLA-B*5101, DRB1*1104, not a CEH). A total of 11 TNF STR blocks were haplotype specific, including a2b5c2d4e3 for CEH 57.1 (Table 2) . Few CEHs showed single TNF STR allele specificity. The common Japanese haplotype CEH 52.1 was the only one that had a13. Similarly, TNFd2 was exclusively present on the Asian CEH 37.1 and TNFe5 on CEH 50.1.
One lineage identified by TNF STR alleles (TNFa11b4c1d3e3 and LTA þ 252A) appeared to be common to CEHs 7.1, 7.2, 54.1 and 60.1. This group of CEHs form a subgroup of the 1SL lineage described before for TNF region haplotypes. 56 These haplotypes are characterized by lower response to lipopolysaccharide. The same four CEHs also carried the same DQA1-HSPA1A/B haplotype; all encoded the Bw6 epitope (SLRNLRG) at the HLA-B locus and C1 epitope at the HLA-C locus. None of the CEHs had the rare TNF STR alleles a14, b8, b9 or d0. 60 We did not do further subtyping of the TNFa locus. 61 Incomplete data on TNF À308 SNP show that only CEHs 8.1 and 58.1 carry the minor allele A (TNF2), 34, 38, 58 which are the only ones that carry the TNF STR haplotype TNFa2b3c1d1e3 and LTA þ 252G (TNFB*1). This block was not shared by the major African DRB1*03 haplotype CEH 42.1 (which carries TNFa6b5c1d3e3, TNF À308G (TNF1), LTA þ 252G (TNFB*1)).
MICA
Despite the presence of published reports on MICA coding sequence and STR allele distribution in HLA haplotypes, 62-71 the data are not complete and insufficient effort has been made to correlate the data with other polymorphisms. We typed all samples in our panel at MICA STR alongside full exons 2-4 typing of the core cell line panel ( We were unable to detect any difference between the cell lines representing CEH 65.1 and other cell lines carrying R6 using the typing system outlined above. The reason may be that amplification products were separated on polyacrylamide gels rather than with capillary electrophoresis. We therefore could not confirm the presence of a variant MICA STR allele.
A SNP at nucleotide 130 of exon 3 of the MICA gene has been found to have functional importance in binding of MICA alleles to NKG2D receptor of natural killer cells. 73 We investigated the relationship of this polymorphism with HLA haplotypes. With one exception (CEH 58.1), the minor allele þ 130A was on the LTA- 70 Rees et al. 71 recently updated the MICA (and MICB) typings that were inconsistent in the literature using a PCR with sequence-specific primers (PCR-SSP) they developed. Most importantly, the cell line EHM -the only reference cell line for MICA*028 -was retyped as heterozygote for MICA alleles *00201/*020 and *00901. We obtained the same result by sequencing-based typing (SBT). Our main focus was the missing or discrepant MICA types for CEHs. We obtained the MICA types for CEHs 35 63 but our result agreed with that of another study. 68 Likewise, we confirmed the MICA type of the cell line HOR as *004 (but not as *007). 63 The cell line CF996 was typed as MICA*019 by us in agreement with some others 68, 71 but not with all. 65, 66 The MICA type of cell line HO301 was *011 but not *008. 66 Taking advantage of our refined SBT scheme, we also addressed few other discrepant results concerning cell lines that do not represent CEHs. These results are presented in Supplementary Table. One noteworthy discrepancy concerns the cell line LUY. This cell line has been typed as MICA*049 71 or as *00901, 66, 68, 69 and listed as heterozygote for *00901 and *049 in the IHWG MICA Panel and IMGT/HLA MICA Sequence Database. Our SBT method typed this cell line as homozygous for MICA*00901 (and STR allele A6). The only difference between MICA*00901 and *049 is at the nucleotide position 109 in exon 3 and LUY has G at this position (not C). This cell line is also homozygous at all other loci analysed in the present study.
HLA class I polymorphisms
We also incorporated the less polymorphic epitope and specific aa position variants with known functional importance into our analysis. These included HLA-A aa116, C1-C2 grouping of HLA-C alleles determined by residues 77 and 80, HLA-Bw epitopes encoded by aa 77-83 and MICA exon 3 þ 130 SNP. These polymorphisms did not contribute to or extend the class III-class II haplotypes constructed by the other polymorphisms analysed. The most common HLA class I haplotype HLA-A-116Y, HLA-C-C1, HLA-Bw6, MICA-130G (Y-1-6-G) was shared by CEH 7.1; 7.2; 8.1; 60.1; 60.2; 60.3 but did not extend to the class III region. The class I haplotype that did not include any of these variants (HLA-A-116S, HLA-C2, HLA-Bw4, MICA-130A; abbreviated as S-2-4-A) occurred only on CEH 57.1. When individually examined against the DQA1 SNP in the class II region, HLA-B epitopes Bw4 and Bw6 showed a noteworthy correlation. HLA-Bw4 and DQA1*499C were present on 11 CEHs among which only one was a rare DRB3 haplotype (CEH 44.4). The others were CEH 37.1 (DRB1*10), CEH 52.1 (DRB5) and eight common DRB4 Identity at all blocks When identity at the HLA class I block (HLA-A aa116, HLA-C1/C2, HLA-Bw4/6, MICA þ 130), class III telomeric block (AIF1, LTA, NFKBIL1), TNF STR, NOTCH4 and HSP-DQA1 blocks was examined, only two pairs of CEHs were identical at all of these. The first pair was 7.1 and 60.1, which also had the same complotype. HLA-B types of these haplotypes (B7 and B40) belong to the same cross-reactive group (group 7C). It is likely that these two haplotypes share a common evolutionary origin. The other pair was CEHs 18.2 and 18.3. Although their reported complotypes differ, we found that they both had the same BF type. The other pairs that showed near identity at the examined loci were CEHs 46.1 and 46.2 (differed only at NOTCH4), and 44.2 and 44.3 (differed only at TNFa).
HLA type updates
The cell lines BSM and BOLETH both represent CEH 62.1 and are identical at all loci listed at the ECACC and IMGT databases except at DRB4. Because of our particular interest in the DRB4 locus, we typed these two cell lines for the DRB4 alleles. The results showed that both cell lines carry DRB4*01030101. These two cell lines (BSM and BOLETH) have also been reported to have different MICB STR alleles (CA21 and CA23, respectively), 67 but we did not analyse the MICB locus.
Non-HLA genes in HLA homozygous/identical cell lines
The cell line HOR (CEH 44.4 by HLA type) is homozygous at all HLA loci examined elsewhere (see IMGT and ECACC databases) but not in the class III locus HSPA1B SNP. Similarly, MANIKA is also homozygous at all HLA loci except DQB1 and the present study showed additional heterozygosity at HSPA1A/B, AIF1 and MICA. The cell line TISI was heterozygous at TNFd as the only example of heterozygosity in this homozygous cell line. Another example was CEH 65.1. The cell lines LWAGS, MZO70782 and PMG075 are all homozygous for B*1402, DRB1*0102 and most of the MHC class III polymorphisms but MZO70782 is heterozygous at HLA-C. 74 MZP70782 and PMG075 are heterozygous at both HSPA1B polymorphisms. The only truly homozygous representative of CEH 65.1 is therefore LWAGS. These findings indicated once more that MHC class III identity cannot be assumed when HLA identity is present.
In contrast, two cell lines identical at MICA and all HLA loci except HLA-DQA1/DQB1 (J0528239 and FPAF) were identical at all non-HLA loci examined. They were different at the DQA1 SNP, reflecting differences in DQA1/DQB1 types (*0501-*0301 and *0103-*0503, respectively, according to IMGT-HLA Database 
Discussion
Conserved extended haplotypes of the MHC have been the subject of many major studies. Despite having the highest density of genes in the genome, the MHC attracted most attention for its HLA gene content. We aimed to confirm and broaden the molecular characterization of CEHs, to resolve inconsistencies and add new information to their allelic content. Many recent studies reported haplotype and LD patterns across the MHC mainly in European Caucasian population samples. [30] [31] [32] [33] 35 We took a similar approach in a reference cell line panel representing more global and complete coverage.
We obtained a detailed profile of non-HLA gene variants within the MHC and examined their relationships with each other, with HLA haplotypes and also with ancestral lineages. As the most comprehensive single study carried out to date, it provides a reference source for the genetic structure of CEHs, and highlights the potential importance of non-HLA genes of the MHC in the design and interpretation of HLA association studies. The ongoing HLA haplotype study 1, 75, 76 will provide much more detailed data for a number of common haplotypes. The cumulative information should lead to new candidate gene studies for certain diseases with established HLA associations. Our study also emphasized the presence of functional HLA polymorphisms that are not related to the antigen presentation but should be considered in the interpretation of HLA and disease associations.
HLA associations may result from the differential ability of the associated allele to present an antigen or autoantigen, or its involvement in shaping the T-cell repertoire in the thymus. These mechanisms usually apply to autoimmune and infectious diseases. 77 Other associations especially with diseases without obvious immunopathology may reflect LD with variants in other nearby genes, as for any other genetic association. Classic examples of this are hereditary haemochromatosis and congenital adrenal hyperplasia, whose genetic basis was first observed as HLA associations but later recognized as due to non-HLA genes of the extended MHC: HFE and CYP21A2, respectively. This study identified previously uncharacterized haplotype-specific variants in HSPA1A promoter, NOTCH4 and NCR3 genes and TNF STR loci of which some were novel. When an HLA allele of these more fully characterized haplotypes is found associated with a condition, a primary non-HLA variant association will have to be examined. For example, the previously reported NCR3 promoter polymorphism À451G4A 78 appeared to be CEH 54.1-specific in this study and may account for the unfavourable influence of HLA-B54 on progression and response to viral infection and treatment. 55, 79, 80 Likewise, HLA-DRB1*15 and its CEH (7.1)
have been associated with a number of conditions such as the protective association in type 1 diabetes (T1D) or risk associations in multiple sclerosis and streptococcal infection progression. Polymorphisms of NFKBIL1 81 and AIF1 28 occur on the DRB1*15 haplotype and a polymorphism in the promoter of NFKBIL1 has been suggested as the alternative explanation for T1D association. 14 The present study showed that the AIF1 polymorphism reported to be specific for CEH 7.1 in a population study 28 is also shared by CEH 60.1. We identified a TNF region block that is shared by CEH 7.1 and closely related to haplotypes (CEHs 7.2; 54.1; 60.1). Identification of such individual or block polymorphisms within non-HLA genes specific to a single haplotype or a group of haplotypes can provide an alternative explanation to an already known HLA association. If the real association is with a central MHC gene, it may even appear as different HLA associations in different populations. An example of this may be an association with a conserved class III haplotype among diverse HLA haplotypes. Conversely, diversity within the class III region among individuals with otherwise HLA-identical haplotypes may also confound disease association studies.
HLA-B*57 is associated with several diseases, the latest one being the risk association of CEH 57.1 with abacavir hypersensitivity. 82 The present study showed that this particular CEH carries unique allelic combinations of the class I variants HLA-A aa116, HLA-C epitopes C1/C2, HLA-B epitopes Bw4/Bw6, MICA exon 3 SNP þ 130G4A and the TNFa-e alleles. The variants that are exclusive to CEH 57.1 may be the basis of associations with HLA-B*57 haplotypes. Our study is not comprehensive enough to provide a standard set of haplotype tagging non-HLA gene polymorphisms, but it has identified markers that may be useful to include in HLA association studies at the outset or after an HLA association has been found.
Besides identifying several haplotype-specific variants, we also unravelled blocks tagging broader groups of HLA haplotypes. One evolutionary grouping encompasses the HLA class II haplotype families characterized by the second expressed DRB genes encoding the supertypes, 83 that is, DRB5, DRB3 and DRB4 haplotype groups. 44 Two groups of HLA class II haplotypes (HLA-DRB4/DRB5 and -DRB3) represent distinct lineages by phylogenetic studies. [84] [85] [86] [87] [88] [89] The evolutionary tree of 58 HLA-DRB1 alleles based on exon 2 sequences shows that these alleles coalesced into 44 lineages by 1.7 million years ago. 86 They further coalesced into two ancestral lineages about 25-30 million years ago with the exception of HLA-DRB1*0701. One of these lineages contains all HLA-DRB1*03, *11/12, *13/14 and *08 alleles examined (the DRB3 group and DRB1*08), whereas the other one contains all DRB1*04, *09, *15/16, *01 and *10 alleles examined (DRB4/5 group and DRB1*01/*10). The use of exon 2 sequences in phylogenetic inference has been challenged. 89, 90 Whereas the intron 2 sequences give the same grouping, the DRB5 lineage appears closer to the DRB3 group when intron 1 sequences are used. 90 Our previous studies showed contrasting patterns of associations with the DRB3 and DRB4 lineages in leukaemias 41, 47, 91 and in Kaposi's sarcoma. 43 Homozygosity for these lineages also shows sex-specific differences in newborns 42 and elderly. 40 In animals, such evolutionarily related haplotypic groups have been used to show correlations between the MHC and sexually selected traits. 92 One of our aims was to unravel haplotypic markers for such broad but related groups.
In this study, we confirmed the previously recognized LD between HSPA1B and HLA-DRB1 alleles. We extended these observations to the HLA class II supertypical families, which represent the ancestral lineages. Two HSPA1A-HSPA1B haplotypes showed the best correlation with the two distinct groups of HLA class II haplotypes (HLA-DRB4/5 and -DRB3). Thus, the two HSP haplotypes mark the supertypical families in agreement with their exon 2 genealogies. The correlation with HSPA1A/B haplotypes agreed more with the intron 2-and exon 2-based genealogy of HLA class II lineages.
The finding that HSPA1B alleles show correlations with HLA-DRB alleles agrees with previous observations that HLA-DR4 (DR53) and -DR15 (DR51) haplotypes are invariably associated with the 9 kb PstI variant (allele A1) of HSPA1B, 3, 93, 94 and the 8.5 kb PstI allele (A2) is in strong LD with HLA-DR3. 94, 95 These previous findings can now be generalized for the principal HLA class II haplotypical families. In non-extended haplotypes, there was no consistent pattern concerning HSPA1B alleles and DR haplotypes. An interesting point is that the data from other studies do not show any correlation between BAT1, TNF (À308), B144, C2, BF or C4 types and the main class II lineages. 39, 52, 53 Similarly, TNFc did not show a correlation in the present study. This unusual correlation between HSPA1B alleles and HLA-DR supertypical loci suggests an ancestral association and a lack of recombination between these genes. In the mouse MHC, a recombinational hotspot exists just telomeric to HSPA1A/B. 96 This particular hotspot is not present in the corresponding region in humans, but there is evidence from a detailed analysis of an MHC haplotype for a recombinational hotspot around the TNF locus (i.e., telomeric to the HSPA1A/B-HLA-DRB fragment). 97 As expected, complotypes show stronger LD with HLA-DRB1 98 and our results suggested that the HSPA1B locus would be in stronger LD with HLA-DRB1. Thus, the HSPA1A/B polymorphisms may be considered as MHC class III lineage markers as they show correlations with evolutionarily ancient HLA class II lineages.
The addition of a single SNP from the DQA1 gene increased the specificity of lineage groupings. The two SNPs at DQA1 and HSPA1B simplified the DRB3/4/5 haplotypic grouping and reduced the MHC class II-class III haplotypes into two groups. Thus, the two main branches of MHC haplotypes can be identified by typing just two SNPs with reasonable specificity. Heterozygosity for these two SNPs would guarantee heterozygosity at almost all polymorphic loci in the class II and class III loci and therefore may be used for a basic test of heterozygote advantage. It is perhaps no chance finding that the DQA1 and HSPA1/B loci showed the best correlation with ancestral groupings of the MHC haplotypes. The HLA-DQA1 locus is indeed known to be a good marker for MHC class II lineages as the most ancient class II locus. [99] [100] [101] The genes encoding HSP70 are highly conserved in all taxa including Drosophila and Escherichia coli 102 (additionally, AIF1 is another ancient locus and functional even in the oldest extant phylum in animal kingdom 103 ).
Using SNPs from three class III genes (AIF1, LTA and NFKBIL1), another grouping was also possible. These variants categorized CEHs in four groups. Although there is still heterogeneity in the intervening loci, most notably at the TNF STR loci, these four haplotypes are other candidates for the ancestral MHC class III lineages. Using such haplotypes sharing an evolutionary history greatly enhances the power of genetic epidemiologic analyses. 104 Such cladistic statistical designs to detect associations between branches of a gene tree and a disease or trait is not new but has been used uncommonly. [105] [106] [107] With the recent development of the Evolutionary-Based Haplotype Analysis Package and appreciation of this method as more optimal than the use of individual SNPs or single haplotypes, 108 this approach is likely to become more popular. Our study has already identified the relevant haplotype groups; their use as genetic markers may help to refine the associations with diseases whose susceptibility loci are suspected to be in the class III region. 4, 11, 109, 110 The validity of these conclusions should await the results of appropriately designed genetic association studies in relevant diseases. In addition to leukaemias, which show associations with HLA class II supertypes DRB4 and DRB3, breast cancer 11 and Hodgkin's lymphoma 111 that are associated with MHC class III markers may be studied for associations with AH groups.
Our results suggested that major alleles of each SNP analysed were represented preferentially on the DRB3 group of haplotypes. Specificity of non-HLA markers to lineages was greater for the DRB3 lineage too. One inference is that the DRB3 family may have been the 'original' MHC haplotype and others have evolved from it. This speculation is also supported by the finding that major DRB3 haplotypes in different continents (e.g., CEHs 8.1; 42.1; 58.1) exclusively share the same combination of SNPs from HLA-DQA1, HSPA1A/B, AIF1, LTA, NFKBIL1 and BAT1 while differing in the intervening polymorphisms. The identity of the three most common African, Asian and Caucasian haplotypes at these loci also suggested the ancestral nature of these loci. The loci that can identify ancestral lineages are in any case more informative than other MHC polymorphisms in whole genome screening studies. Identification of such AH consisting of alleles of highly conserved loci may even allow comparative studies in different species. These data, along with data from other studies, can also be used for phase assignments for population-based haplotype studies.
In this study, we completed the TNF STR, HSPA1A/B, BF and MICA typings of all CEHs, provided new polymorphism data for them, identified new haplotype-specific variants in the HSPA1A promoter, described new markers for ancestral lineage inference and resolved inconsistencies from previous studies. The study represents a different approach to study the SNP repertoire of the MHC using a sufficiently representative set of SNPs. One limitation was its restriction to CEHs, which make up about one-third of HLA haplotypes segregating in the population. 39 The relationships observed may still be sufficient to cause LD at the population level. We hope that the results will encourage researchers to interpret HLA associations with a wider perspective. This should include considerations of non-HLA genes as confounders of HLA associations and avoidance from conclusions like an HLA association necessarily suggests an immunologic basis for the disease. We also predict a gradual shift towards the whole of the MHC in immunogenetic studies from solely high-resolution typings of HLA loci.
Materials and methods
Reference cell lines A panel of IHW reference cell lines was analysed for polymorphisms of the MHC genes. The 101 cell lines used in this study are shown in Table 1 
Other samples
To increase the reliability of the results by replication, 10 additional HLA-B-DRB1 homozygous samples from normal populations were included in the study. Three of these samples from our previous newborn study (origin: South Wales, UK) 42 carried B*0801-DRB1*0301, B*1302-DRB1*0701 and B*4402-DRB1*0401, respectively; two samples from bone marrow donors from the Korea Marrow Donor Program (KMDP) 112 carried B*3701-DRB1*1001; two samples from a Mongolian population study 113 carried B*5801-DRB1*0301; and two samples from a Zambian HIV-1 transmission study 114 carried B*4201-DRB1*0302. All had the same HLA and non-HLA gene polymorphisms as the corresponding CEHs. In the absence of an existing cell line homozygous for B*3701-DRB1*1001, the two Korean samples provided the first direct immunogenetic profile of this haplotype.
Genotyping procedures
All typings were at the DNA level. PCR amplifications and cycle sequencing reactions were run in the DNA thermal cycler (MJ Research Inc., Waltham, MA, USA); STR typings and SBT were performed on ALFexpress DNA Analysis System II (Amersham Biosciences Corp., Piscataway, NJ, USA). For STR typing, one of the primers was labelled with Cy5. For primer cycle sequencing, we used the Thermo Sequenase Primer Cycle Sequencing Kit (Amersham Biosciences Corp., Piscataway, NJ, USA). Electropherograms were analysed by visual examination. Preferred DNA polymerase for PCR typings was Taq DNA Polymerase (New England BioLabs Inc., Beverly, MA, USA) unless the product size was more than 2 kb; then Platinum Taq Polymerase (Invitrogene, Carlsbad, CA, USA) was used. TNFb STR typings required the Platinum Genotype Tsp DNA Polymerase (Invitrogene, Carlsbad, CA, USA), specifically designed for dinucleotide repeat polymorphism typings and does not add nontemplated nucleotide to the end of the amplicon. New England Biolabs Inc. (Beverly, MA, USA) supplied all restriction endonuclease enzymes, and MWG Biotech Inc. (High Point, NC, USA) synthesized all primers including Cy5 labelling. All PCR protocols included an initial denaturation at 951C (10 min) and a final extension at 721C (7 min) step. All primer sequences are given in the 5 0 to 3 0 orientation. The loci analysed in this study are shown in Figure 1 .
Nucleotide numberings used the translation initiation site as nucleotide þ 1 as recommended. 115 The corresponding nomenclature for some previously studied polymorphisms, which was based on numbering in reference to transcription start site, is also given as appropriate. Similarly, gene names are given as described in the NCBI Entrez Gene database along with their better-known aliases when necessary. Reference GenBank entries are identified with their GI (GenInfo Identifier) numbers, which are unique to the version used. For polymorphisms, NCBI SNP Database ID numbers are given when available.
Additional loci could not be studied owing to various constraints. The loci examined were deemed to be most relevant to disease associations with the ancestral HLA class II lineages we have previously reported. Priority was given to loci known to be ancestral (HLA-DQA1, HSPA1A/B, AIF1), loci associated with leukaemias in other studies (BF), loci inconsistently associated with reported CEHs (BF, MICA) or loci previously studied but incompletely characterized for their associations with CEHs (TNF STR loci).
HLA-DQA1 3
0 UTR SNP An earlier study reported a BglII RFLP in the HLA-DQA1 gene. 46 We located the SNP responsible for this polymorphism that showed correlation with major HLA class II haplotypic groupings to the 3 0 UTR of the DQA1 gene (SNP ID: rs1142316). The primers DQA1F 5 0 -CAC CAA GGG CCA TTG TGA AT and DQA1R 5 0 -AGG GTG GGA ACA CAA GGA AG amplified a 726 bp fragment. Subsequent digestion with BglII yielded 513 and 213 bp fragments when the nucleotide 499 of 3 0 UTR was C (as in HLA-DQA1*0103; GI: 22255897) and was uncut when it was A (as in HLA-DQA1*0501; GI: 22255975). In accordance with the current recommendations (see http://www.hgvs.org/mutnomen), we describe this SNP as NT_034874:g.5833C4A. Alternatively, as a 3 0 UTR polymorphism, it may be called HLA-DQA1 SNP *499C4A (meaning a SNP at nucleotide 499 after translation termination) as recommended by the Human Gene Mutation Database (Nomenclature for the description of sequence variations: http://archive.uwcm.ac.uk/ uwcm/mg/docs//mut_nom.html).
HSPA1A and HSPA1B SNPs and STR Two polymorphisms in HSPA1B (HSP70-2) and promoter polymorphisms in HSPA1A (HSP70-1; HSP72) were typed. An A to G substitution at position þ 1267 in the HSPA1A and HSPA1B genes results in a restriction site recognized by the restriction endonuclease PstI. 21, 116 This synonymous substitution is within the coding region (aa position 351; SNP ID: rs1061581). The distribution of the HSPA1B (HSP70-2) PstI alleles in the MHC haplotypes was studied by Southern blotting. 2, 3, 22, 47, 48 In the present study, a PCR-RFLP system was used to type this polymorphism within the HSPA1B gene. The HSPA1B-specific amplification primers were HSPPSTF 5 0 -CAT CGA CTT CTA CAC GTC CA and HSPPSTR 5 0 -CAA AGT CCT TGA GTC CCA AC. Amplification conditions were 30 cycles of denaturation at 941C for 30 s, annealing at 521C for 30 s and extension at 721C for 1 min. The 1117 bp amplification product was digested with PstI. There is also a biallelic pentanucleotide duplication polymorphism (183 bp (A1) and 188 bp (A2)) in the 3 0 UTR of the HSPA1B gene (SNP ID: rs9281590). 117 The presence of the duplication (allele A2) associates most commonly with the presence of the PstI site (1267G) in HSPA1B. 117, 118 The primers used for the pentanucleotide polymorphism analysis in the present study are from Dressel and Gunther. 117 Amplification conditions were 30 cycles of denaturation at 941C for 30 s, annealing at 551C for 30 s and extension at 721C for 1 min.
The 5 0 regulatory region of HSPA1A has two SNPs 21 usually detected by mobility differences on a polyacrylamide gel. 23, 119 We used cycle sequencing to type the SNPs À325T4G (rs1008438) and À26C4G (rs1043618) -corresponding to À110 and þ 190 SNPs in reference to the cap site, respectively -using the 610 bp amplicon obtained by the following primers: HSPSBTF 5 0 -CTG TCA ATT AGG CGC TGA AGC (HSPA1A-specific primer, 504-524 bp upstream of translation initiation site); HSPSBTR 5 0 -TGA TCT CCA CCT TGC CGT GTT (61-81 bp downstream of translation initiation site that is common to HSPA1A and HSPA1B). The sequencing primer was HSPSBT 5 0 -Cy5-CAC GCA GGA GTA GGT GGT (54-37 bp downstream of translation initiation site). All nucleotide positions are according to the GenBank sequence GI: 4529886.
Sequencing of 5 0 regulatory region of HSPA1A revealed another SNP previously unknown (see Results). This new polymorphism was À130G4C, which created a restriction site for AluI. We did further typings of this SNP using RFLP analysis. Amplification primers were the same as those used for amplification before SBT (HSPSBTF and HSPSBTR).
NOTCH4 STR and SNP
There is a CTG trinucleotide repeat polymorphism (D6S1014) in the first exon of NOTCH4. 120, 121 The CTG repeats code for polyleucines in the signal peptide (beginning with the sixth aa). This polymorphism has been studied in Japanese cell lines, healthy individuals and patients with certain diseases using an imperfect method. 26, 121, 122 The original method depended on the presence of a Sau3AI site within the gene and chromosomes lacking this site could not be typed because of large fragment size for STR analysis. In the present study, this requirement was eliminated by using newly designed primers and PCR conditions originally described by Ujike et al. 123 In addition to the CTG repeat polymorphism, a Sau3AI polymorphism within the first intron (IVS1 þ 52A4T; or 122A4T in reference to the translation initiation site; GI: 12248890) was examined using the original PCR-RFLP analysis.
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AIF1 SNP
The SNP in the first intron of AIF1 (IVS1 þ 24C4T; SNP ID: rs2844475) was typed by AciI PCR-RFLP using the amplification primers AIFACIF 5 0 -TCT CCA CCG CCT ACA GTT TC and AIFACIR 5 0 -GCC TCC AGC TTG GTC TGT CT (annealing temperature: 551C). The amplicon was 482 bp long.
NCR3 SNPs
Two already known SNPs in the promoter region of NCR3 were typed. 78 The À412G4C polymorphism (SNP ID: rs2736191) was typed by PstI PCR-RFLP method (reference sequence: GI: 4337095). The primers were NCR3PF 5 0 -CAC ACA AGG TGA TTG CTA TGC and NCR3PR 5 0 -CAG GGT CTC TAG GAG GCC AA (annealing temperature: 581C). The other polymorphism, À451A4G, was typed by PCR-SSP. The allele-specific primers were NCR3PA1 5 0 -TGG TGA GCA GCA GGG AGG and NCR3PA2 5 0 -TGG TGA GCA GCA GGG AGA; the generic primer was NCR3PR (annealing temperature: 601C).
NFKBIL1 SNP
The SNP in the promoter of NFKBIL1, À62A4T (SNP ID: rs2071592), was typed by the PCR-SSP method described by Ahmad et al. 32 (À135A4T from the translation initiation site; reference sequence: GI: 27544429). The primer sequences were NFKBIL1F 5 0 -CGT CCA TCA CTG AAC CAT CT, NFKBIL1RA 5 0 -GGC GCA AGC AGA GAC GCT and NFKBIL1RT 5 0 -GGC GCA AGC AGA GAC GCA (annealing temperature: 581C).
BF
Conventionally, BF typing is carried out by isoelectrofocusing. In this study, we did molecular BF typing using one PCR and two restriction endonucleases. This scheme does not reveal the genetic basis of extensive polymorphism at the protein level but distinguishes three predominant allelic groups: S, FA and FB. 124, 125 The amplification primers were BFF 5 0 -GCC TCT TGT CTG GAG GTA AG and BFR 5 0 -GCA CAG GGT ACG GGT AGA AG, yielding a 252 bp fragment spanning exons 1 and 2 (annealing temperature: 561C). Restriction enzyme TaqI was used to distinguish BF*S from BF*F. Further characterization of BF*F subtypes (BF*FA and *FB) was achieved by BslI digestion.
LTA SNP
The SNP þ 252A4G (IVS1 þ 90A4G; SNP ID: rs909253) in the first intron of LTA (TNFB) was typed by NcoI PCR-RFLP. The primers were LTAF 5 0 -CTC CTG CAC CTG CTG CCT GGA TC and LTAR 5 0 -GAA GAG ACG TTC AGG TGG TGT CAT (annealing temperature: 651C). This LTA SNP is reported to be in strong LD with the TNF promoter SNP À308G4A (SNP ID: rs1800629). 126 We did not type the À308 SNP of TNF but incorporated the data available on some of the cell lines and CEHs in the literature. 34, 38, 58 TNF STR loci The TNFa-e STR primers and amplification conditions were from Udalova et al. 53 The forward primers were labelled with Cy5.
MICA MICA typing was carried out by sequencing of three polymorphic exons (2-4). The sequencing scheme was based primarily on the report by Katsuyama et al. 64 In the first step, a 2.2 kb fragment of the MICA gene was amplified by generic primers. For sequencing exons 2-4, exon-specific nested primers were used. We modified the original primers slightly to increase their specificity for MICA to avoid any amplification of MICB. 127 The modified generic primers were MICF 5 0 -TCC TCG TTC  TTG TCC CTT TGC CCG and MICR . This area of intron 1 has an indel polymorphism and causes preferential amplification (and subsequent allelic dropout) in samples heterozygote for certain MICA alleles. Reference sequences for intron 1 indel polymorphisms are GI: 557554 (HLA-B57,DR7 haplotype) and GI: 557557 (HLA-B18,DR3 haplotype). The modified exon 2 forward primer corresponds to nucleotides 6926-6953 and spans the intron/exon junction. Further details are given elsewhere. 127 
MICA STR
The MICA gene contains a trinucleotide repeat polymorphism in exon 5. This typing was based on the published method of Mizuki et al. 128 The primers were MEX5F 5 0 -CCT TTT TTT CAG GGA AAG TGC-3 0 and MEX5R 5 0 -CCT TAC CAT CTC CAG AAA CTG C-3 0 . MEX5F was Cy5 labelled and the genotyping was performed on ALFexpress DNA Analysis System II.
We only typed the cell lines that had inconsistent MICA results in the literature or representatives of CEHs with missing data 63, 64, [67] [68] [69] [70] [71] 128 (see Table 1 footnote). Our results were complemented with the data from IHWG Cell Line Bank (http://www.ihwg.org/shared/cbankover.htm) for cell lines represented in the MICA Reference Panel and IMGT/HLA Sequence Database (http:// www.ebi.ac.uk/imgt/hla/allele.html).
HLA
We typed five of the samples in our panel previously typed only at low resolution at HLA-B (see Table 1 footnote), by high-resolution typing using a reference strand conformation analysis kit (Pel-Freez Clinical Systems, Brown Deer, WI, USA). To resolve a conflict regarding the DRB4 type of the cell lines BSM and BOLETH, both representing the CEH 62.1, we typed their DRB4 alleles using Fastype HLA-DNA SSP typing system (Bio-Synthesis Inc., Lewisville, TX, USA). 
